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Abstract: The most common technology for seizure detection is with 
electroencephalography (EEG), which has low spatial resolution and 
minimal depth discrimination. Optical techniques using near-infrared (NIR) 
light have been used to improve upon EEG technology and previous 
research has suggested that optical changes, specifically changes in near-
infrared optical scattering, may precede EEG seizure onset in in vivo 
models. Optical coherence tomography (OCT) is a high resolution, 
minimally invasive imaging technique, which can produce depth resolved 
cross-sectional images. In this study, OCT was used to detect changes in 
optical properties of cortical tissue in vivo in mice before and during the 
induction of generalized seizure activity. We demonstrated that a significant 
decrease (P < 0.001) in backscattered intensity during seizure progression 
can be detected before the onset of observable manifestations of generalized 
(stage-5) seizures. These results indicate the feasibility of minimally-
invasive optical detection of seizures with OCT. 
© 2012 Optical Society of America 
OCIS codes: (110.4500) Optical coherence tomography; (170.3880) Medical and biological 
imaging; (100.2960) Image analysis. 
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1. Introduction 
Epilepsy, affecting at least 2% of the population [1], encompasses a group of disorders of the 
brain characterized by the periodic and unpredictable occurrence of seizures. As seizures are 
intermittent in patients with epilepsy, detection of seizures before they occur would be 
revolutionary in both warning patients and also developing “closed-loop” seizure detection 
and termination paradigms. To date, seizure detection algorithms have been solely based on 
analysis of either surface or intracranial electroencephalography (EEG). However, EEG has 
low spatial resolution, minimal depth discrimination and high susceptibility to electrical noise 
and motion artifacts. While great efforts are underway, there are currently no real-time 
methods of EEG analysis capable of reliably and reproducibly predicting seizure onset [2,3]. 
Optical techniques using near-infrared (NIR) light have been implemented to improve 
upon EEG technology by decreasing noise and increasing spatial and temporal resolution 
[4,5]. Previous research has suggested that optical changes, specifically changes in near-
infrared optical scattering, may precede EEG seizure onset in animal models and that these 
optical changes are due to pre-seizure physiological changes, in particular reduction in the 
extracellular space [5–8]. Due to changes in the optical properties of the tissue, a decrease in 
intensity of backscattered light has been observed during the progression of seizures using 
noncontact NIR imaging and fiberoptic probes [5,7,9]. 
Optical coherence tomography (OCT) is a high resolution, minimally invasive, imaging 
technique which uses the short temporal coherence of a broadband light source to create 
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cross-sectional images in real time [10,11]. OCT has shown to be a promising method for in 
vivo imaging in highly scattering tissues such as the cerebral cortex and several groups have 
demonstrated that through functional OCT imaging, changes in tissue composition can be 
detected optically during stimulation [12–16]. In this study, we demonstrated that changes in 
the optical properties of brain tissue during the progression of seizures can be detected with 
the use of spectral-domain optical coherence tomography (SD-OCT) [17] by inducing a 
generalized seizure, measuring the changes in the backscattered intensity from the imaged 
tissue over time, and then quantifying these changes. 
2. Materials and experimental methods 
2.1 Animal preparation for in vivo experimentation 
6-8 week old, CD1 female mice (25-35 g) were initially anesthetized intraperitoneally (i.p.) 
with a combination of ketamine and xylazine (80 mg/kg ketamine, 10 mg/kg xylazine) and 
anesthesia levels were carefully monitored via breathing rate and reflexes. A 4x4 mm thinned 
skull cortical window was created with a dental bur over the cerebral cortex. The skull was 
thinned to a uniform 55 µm. The mice were then imaged and a 10 min baseline was collected 
before a saline control injection was administered. After 25 to 30 min, pentylenetetrazol 
(PTZ) (100 mg/kg) was injected i.p. to induce a seizure. PTZ is a GABAA antagonist that 
reproducibly causes generalized seizures in this mouse model with a latency after injection 
[18], allowing for the study of the optical characteristics of the post-injection, pre-seizure 
state. Once a generalized tonic-clonic (stage-5) seizure was observed, involving fore- and 
hind-limb twitches and tail movement, the animal was sacrificed with an anesthesia overdose. 
All experimental procedures were approved by the University of California, Riverside 
Institutional Animal Care and Use Committee. 
2.2 Spectral-domain optical coherence tomography (SD-OCT) 
An SD-OCT system [17,19–21] optimal for imaging cortical tissue in vivo, utilizes a NIR 
light source centered at 1300 nm, providing an imaging depth of a few millimeters as well as 
achieving high spatial resolution [22]. The SD-OCT system we developed used a broadband, 
low-coherence light source consisting of two superluminescent diodes (SLD) centered at 1295 
nm with a bandwidth of 97 nm, resulting in an axial and lateral resolution of 8 μm and 20 μm 
respectively. In our system, the source was split between a sample and reference arm with an 
80/20 fiber coupler [23]. After recombination, the now interfered light was sent to a 
spectrometer where it was incident on a 1024 pixel InGaAs line scan camera (lsc) (Fig. 1). 
 
Fig. 1. Schematic of the SD-OCT system. SLD: superluminescent diode, lsc: line scan camera, 
gm: galvanometer. 
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2.3 Image acquisition and data processing 
To image the mouse brain, we continuously scanned the motor cortex region of the right 
hemisphere centered over the corpus callosum. An imaging depth of 2 mm was obtained with 
6 mW of incident power and a focal point 1 mm below the thinned skull. Axial line scans (A-
lines) were acquired at 15 kHz, with each cross-sectional image consisting of 2048 A-lines 
spanning a 3 mm imaging plane. The spectral data was then sent to the graphics processing 
unit (GPU) where, to correct for the nonlinear k-space sampling interval, 512 sampled points 
per A-line scan were mapped to uniform frequency spacing by linear interpolation [24]. The 
GPU also handled the Fourier-transformation into the spatial domain and secondary image 
processing, including plotting the intensity images on a logarithmic inverse gray scale (Fig. 2) 
[23]. In SD-OCT, the sensitivity of the system decreases as a function of depth due to the 
finite resolution of the spectrometer and because of this, we applied a depth-correction 
function, reported by Yun et al. [24], during image processing by multiplying each A-line by 
the calculated correction curve. By applying the depth-correction, it also insured any change 
in tissue intensity was caused by biological effects not axial movement of the sample in the 
imaging window. 
3. Results and discussion 
3.1 Calculating average intensities from regions of interest 
To analyze the changes in backscattered intensity resulting from changes in tissue 
composition during seizure progression, we calculated average intensities from regions of 
interest (ROI) over time. Our images had a maximum SNR of 45 dB above the noise floor and 
when selecting our ROIs we were careful to avoid regions where the SNR dropped below 10 
dB. The ROIs we selected were approximately 1 mm deep and 3 mm wide and included all 
the cortical tissue in the imaging window because we were interested in the overall trend in 
intensity exhibited by the tissue. Minor variations in the ROI shape do not affect the final 
average intensity due to the high intensities of the selected regions (Fig. 2). To produce the 
results in Fig. 2, an image was analyzed every 10 s and the average intensities, which were 
normalized to the 10 min baseline, were plotted versus time. We also used a reference 
reflector during our experiments and analyzed small ROIs over time to ensure any changes 
were from biological phenomena and not system artifact. 
3.2 Experimental controls 
When designing our experiment, we used two controls. The first was a time sequence of 
baseline measurements, which were obtained prior to any experimental injection over the 
course of 10 min. The second was a saline injection with a volume equivalent to the PTZ 
dosage. This injection directly followed the baseline and post injection data was acquired for 
25-30 min to establish if an injection alone causes a change in backscattered intensity from the 
imaged cortical tissue. In order to determine whether the saline injection caused any 
significant change in intensity, we calculated a two standard deviation (2SD) interval above 
and below the mean of the baseline spread and plotted the intervals in Fig. 2 to establish a 
high and low threshold for the intensity data. Due to low variability in the baseline data for all 
four experiments, we are able to construct narrow threshold intervals allowing us to detect 
even minor changes in intensity throughout experimentation. 
It is apparent that there is no significant change in intensity during our controls (Fig. 2). 
To quantify our results, we calculated the baseline and post saline injection slopes through 
linear regression of the data in Fig. 2B for all four experiments. The intervals, from which the 
baseline slopes were calculated, began at time zero and ended at saline injection and the post 
saline injection slopes were calculated from the administration of the saline injection to PTZ 
injection. The average baseline slope was −0.16 x 10−3 NI/t and the average post saline 
injection slope was −0.59 x 10−3 NI/t. We used a Tukey multiple comparisons test to compare 
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baseline, post saline injection, and post PTZ injection slopes and our results indicated no 
significant change in intensity between baseline and post saline inj. with a P-value of 0.9997. 
 
Fig. 2. Reduction in intensity during seizure progression. (A) OCT images of mice brain, one 
for each experiment, acquired in vivo with axial and lateral resolutions of 8 µm and 20 µm 
respectively. The red boxes indicate the ROIs used for average intensity calculations. The scale 
bar is 0.5 mm. (B) Plots of normalized intensity (NI) from the ROIs on left over time. The 
occurrences of the experimental steps are indicated: S: Saline injection (first red bar), PTZ: 
PTZ injection (second red bar), FMJ: Facial myoclonic jerks (green dashed line), FS: Full 
stage-5 seizure (blue dashed line). The gray region is the 2SD interval above and below the 
mean of the 10 min baseline. 
3.3 Detection of optical changes during seizure progression 
Directly after the saline control, we administered the PTZ injection to induce a seizure. OCT 
images were continuously acquired through the onset of a stage-5 seizure. The same ROI 
analysis was performed as was done for the controls and the resulting average intensities were 
plotted verses time in Fig. 2B. In all four experiments, a decrease in backscattered intensity 
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post PTZ injection was observed. This decrease from normal is due to the change in tissue 
composition, which precedes the onset of a seizure [6–8]. The average intensity in the ROI 
was monitored as it decreased below the 2SD threshold. Variability between when PTZ 
injection occurred and when the threshold was crossed in each experiment was due to the 
noise in the baseline spread from which the 2SD threshold was calculated (Fig. 3). Soon after 
the threshold was crossed, we observed facial myoclonic jerks (FMJs) (Fig. 2), which are 
events associated with the early stages of seizure progression [25]. The timing from when the 
threshold was crossed to when the FMJs were observed varied between experiments, ranging 
from 1 to 10 min. However, the threshold crossing always occurred at least a minute before 
the first observed FMJs. This indicated that a significant decrease in intensity from baseline 
can be detected with OCT before the onset of observable physical manifestations associated 
with early stages of seizures. Also, because of the narrow threshold interval, we detected a 
significant decrease in intensity, even in the experiments where the total percent decrease 
from baseline was under 10%. 
 
Fig. 3. OCT-detected “optical threshold” precedes myoclonic jerks and full seizure. Latency 
from PTZ injection (min) displayed for optical threshold (defined as 2SD change in intensity), 
myoclonic jerks, and full stage-5 (generalized tonic-clonic) seizure. Optical threshold crossing 
preceded both myoclonic jerks (focal seizure) and generalized seizure, indicating the ability of 
OCT to optically detect pre-seizure state. 
3.4 Analysis of changes during experimental steps 
We imaged through the initiation of a stage-5 seizure, which due to the variability in 
anesthesia levels occurred at different time points after PTZ injection (Fig. 3). As the seizures 
progressed, the intensity from the imaged areas continued to decrease. To quantify the 
changes in intensity, we calculated the slopes post PTZ injection for each of the four 
experiments using linear regression. The intervals for the slope calculations began at PTZ 
injection and ended once the data began to deviate from the linear decreasing trend. We then 
averaged the four slopes and plotted them in Fig. 4 along with the baseline and post saline 
injection average slopes. The interval bars in Fig. 4 were calculated by a 90% confidence 
interval (C.I.) using the t-distribution for small sample sizes. The average slopes and intervals 
for each of the three experimental steps were: baseline −0.16 x 10−3 ± 0.99 x 10−3 NI/t, post 
saline inj. −0.59 x 10−3 ± 0.81 x 10−3 NI/t, and post PTZ inj. −5.3 x 10−3 ± 1.99 x 10−3 NI/t. 
The differences in the slopes between experimental steps were analyzed with an ANOVA 
F-test and the results are summarized in Table 1. Even with slope variability between the four 
experiments, there is a significant difference between the treatments (P < 0.001), indicating 
that the mean slopes for all three steps are not equal. 
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Fig. 4. Plot of the three average slopes: Baseline, Post saline injection, and Post PTZ injection. 
The average slopes were calculated from four seizure experimental data sets. The interval bars 
were calculated with a 90% confidence interval using the t-distribution. NI: Normalized 
Intensity, t: time (min), Inj.: Injection. 
Table 1. ANOVA for the average slopes of the three experimental steps 
 df Sum of Square Mean of Square F-value P-value 
Treatment 2 5.98 x 10−5 2.99 x 10−5 22.34 1 x 10−4 
Error 9 1.2. x 10−5 1.34 x 10−5   
        df: degrees of freedom 
To explore the differences found with the ANOVA F-test, we performed a Tukey multiple 
comparisons test to compare the baseline, post saline, and post PTZ slopes. As mentioned 
previously in Section 3.2, the baseline and post saline slopes were not significantly different. 
This procedure also compared the post PTZ injection slopes to the baseline and post saline 
injection slopes. The resulting P-values were P < 0.001 for both comparisons: post PTZ 
injection slope to the baseline slope and post PTZ injection slope to the post saline injection 
slope. This demonstrates that the change in backscattered intensity as a seizure progresses can 
be quantified and when compared with pre-seizure states, signifies that there is a significant 
decrease in intensity, detectable with OCT. 
4. Conclusion 
In conclusion, we conducted seizure experiments in vivo to establish, as a proof of principle, 
that a decrease in intensity during seizure progression can be detected through OCT imaging. 
We created a threshold interval model for the temporal identification of changes in the 
backscattered intensity. Our results indicated that crossing below the definable optical 
detection threshold occurred prior to either FMJs or generalized (tonic-clonic) manifestations 
of seizure activity. In the future, we plan on further developing this into an optical trigger to 
help identify the occurrence of seizures prospectively even before physical manifestations are 
present. These results could lead not only to optical seizure detection but also prediction with 
appropriate algorithmic real-time analysis of the OCT signal. Furthermore, previous research 
has used OCT to spatially resolve changes in cortical tissue during electrical stimulation 
[14,15] and by utilizing the high spatial and temporal resolution of OCT, it will be possible to 
map changes in intensity during seizure progression and propagation through the intact brain. 
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